Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MiAlgae is a biotechnology company based in Scotland that specializes in the production of omega-3 rich microalgae through a circular economy approach. The company utilizes nutrient-rich co-products from the whisky distillation industry as a feedstock to grow microalgae, providing a sustainable alternative to fish oil. Their flagship product, NaturAlgae, is a dried microalgae powder high in docosahexaenoic acid and other oils, primarily targeting the aquaculture and pet food markets. By decoupling omega-3 production from marine sources, MiAlgae aims to reduce overfishing and the environmental impact of traditional fish oil supply chains. The company operates a commercial-scale demonstrator site and is expanding its manufacturing capabilities to meet global demand for sustainable ingredients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MiAlgae.